Safety, Side Effects, and Monitoring Review safety considerations before starting or switching semaglutide because GLP-1 medicines affect digestion, glucose levels, and several risk areas
Injection-site reactions are a recognised consideration for subcutaneously administered agents of this class and will be further characterised in Phase 3 data
Once that date passes, potency declines, and results may weaken, so replace the medication promptly
After adjusting for age and sex as potential confounders, the association between creatinine and AUC difference remained significant ( = 20.8, 95% CI: 0.7, 40.8
Genetic engineering opened up a new way to manufacture human proteins previously difficult to obtain in large quantities